Hospira Dacarbazine for Injection BP, 200 mg vial

Država: Australija

Jezik: engleski

Izvor: Department of Health (Therapeutic Goods Administration)

Aktivni sastojci:

dacarbazine, Quantity: 200 mg

Dostupno od:

Hospira Australia Pty Ltd

INN (International ime):

Dacarbazine

Farmaceutski oblik:

Injection, powder for

Sastav:

Excipient Ingredients: citric acid monohydrate; mannitol; sodium hydroxide

Administracija rute:

Intravenous

Jedinice u paketu:

1 x 20 mL vial

Razred:

Medicine Listed (Export Only)

Tip recepta:

Not scheduled. Not considered by committee

Terapijske indikacije:

Dacarbazine is indicated for the treatment of patients with metastatic malignant melanoma. Dacarbazine is used as part of combination chemotherapy for the treatment of advanced Hodgkin's disease, advanced adult soft tissue sarcomas (except mesothelioma and Kaposi sarcoma). Dacarbazine has been shown, when used in combination with other cytotoxic agents, to be of use in the treatment of other malignant diseases including carcinoma of the colon, ovary, breast, lung, testicular teratoma, and solid tumours in children.

Proizvod sažetak:

Visual Identification: A white or very pale yellow powder or plug; Container Type: Vial; Container Life Time: 18 Months

Status autorizacije:

Licence status A

Datum autorizacije:

2006-02-15